CTRI/2024/06/068878尚未招募4 期
Efficacy And Safety Of Add On Aprepitant to standard antiemetic regimen for concurrent chemoradiotherapy induced nausea & vomiting in locally advanced head & neck squamous cell carcinoma : A Randomized, Double Blind, Controlled Clinical Trial - NI
Pt BD Sharma UHS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Histologically confirmed cases of squamous cell carcinoma in head & neck region with any stage between Stages III-IV B.
- •Patients with ECOG performance status 0–1
- •Patients with adequate organ and bone marrow function.
- •Patient is able to swallow tablets
排除标准
- •advanced stage malignancies(above Stage IVB)
- •History of nausea and emesis occurred 24h before the start of CCRT.
- •Conditions like severe cardiovascular, pulmonary, diabetic, mental, and other diseases.
- •Pregnant or lactating females.
- •Drug h/o corticosteroid or benzodiazepines.
- •History of Drug/Alcohol addictions.
- •N&V provoking conditions like brain metastasis, gastrointestinal obstruction, hypocalcemia;
研究者
相似试验
招募中
3 期
Evaluation of the efficacy of Aprepitant in vomiting of children with cancerMalignant cancer.Agranulocytosis secondary to cancer chemotherapyD70.1IRCT20200204046377N1Shahid Beheshti University of Medical Sciences30
招募中
2 期
Evaluation of the efficacy and safety of lacosamide to duloxetine in the treatment of taxanes- induced peripheral neuropathyTaxane-induced neuropathy.IRCT20090613002027N21Mazandaran University of Medical Sciences60
已完成
不适用
Investigation of efficacy and safety of add-on therapy with DPP-4 inhibitor in type 2 diabetic patients poorly controlled with basal supported oral therapyType 2 diabetesJPRN-UMIN000010849Department of Metabolism & Endocrinology Juntendo University Graduate School of Medicine40
尚未招募
2 期
Evaluation of effective and safe use of a new drug Apremilast [a Phosphodiesterase enzyme inhibitor (PDE-4 inhibitor)] in patients suffering from unstable white patch-a skin condition called vitiligo.CTRI/2019/07/020234AIIMS JODHPUR
已完成
不适用
Evaluation of combinational effect of Aprepitant and Dxamethasone on nausea and vomiting induced by high-emetic-risk chemotherapy in patients.JPRN-UMIN000010818Osaka Medical College Hospital200